Tadimeti S Rao Selected Research

4- ((2- (1- methyl- 2- pyrrolidinyl)ethyl)thio)phenol hydrochloride

10/2003

In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadimeti S Rao Research Topics

Disease

5	Pain (Aches) 11/2011 - 05/2009
3	Inflammation (Inflammations) 01/2021 - 01/2012
2	Rheumatoid Arthritis 01/2020 - 01/2019
2	Endotoxemia 08/2015 - 07/2009
2	Hyperalgesia 11/2011 - 02/2011
2	Neuralgia (Stump Neuralgia) 11/2010 - 05/2009
2	Neoplasms (Cancer) 12/2008 - 05/2008
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Hypersensitivity 01/2021
1	Eosinophilia 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Infections 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2013
1	Edema (Dropsy) 02/2011
1	Parkinson Disease (Parkinson's Disease) 10/2008
1	Prostatic Neoplasms (Prostate Cancer) 05/2008
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2008
1	Demyelinating Diseases (Demyelinating Disease) 10/2004
1	Autoimmune Diseases of the Nervous System 08/2004
1	Gliosis 05/2004
1	Cognitive Dysfunction 10/2003

Drug/Important Bio-Agent (IBA)

4	Formaldehyde (Formol)FDA Link 02/2011 - 05/2009
3	4- ((2- cyclobutyl- 1H- imidazo(4,5- b)pyrazin- 1- yl)methyl)- 7,8- difluoroquinolin- 2(1H)- oneIBA 02/2011 - 05/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2012 - 02/2011
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 02/2011 - 11/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2011 - 05/2009
2	QuinolonesIBA 11/2010 - 05/2009
2	Histone Deacetylase InhibitorsIBA 12/2008 - 05/2008
2	KD 5170IBA 12/2008 - 05/2008
1	Interleukin-13IBA 01/2021
1	AntibodiesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	CytokinesIBA 01/2020
1	CollagenIBA 01/2020
1	AutoantibodiesIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	LipopolysaccharidesIBA 08/2015
1	Phosphotransferases (Kinase)IBA 12/2013
1	EnzymesIBA 01/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2012
1	Biological ProductsIBA 01/2012
1	imidazoleIBA 11/2011
1	Celecoxib (Celebrex)FDA Link 02/2011
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 02/2011
1	Pregabalin (Lyrica)FDA Link 02/2011
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2011
1	Capsaicin (Zostrix)FDA Link 02/2011
1	CarrageenanIBA 02/2011
1	phenylbenzoquinoneIBA 02/2011
1	benzimidazoleIBA 11/2010
1	N- (3- chlorophenyl)- N- ((8- fluoro- 2- oxo- 1,2- dihydroquinolin- 4- yl)methyl)- 4- methylthiazole- 5- carboxamideIBA 07/2009
1	Histones (Histone)IBA 12/2008
1	Antidepressive Agents (Antidepressants)IBA 10/2008
1	altinicline maleateIBA 10/2008
1	Vorinostat FDA Link 05/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2008
1	Docetaxel (Taxotere)FDA Link 05/2008
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2004
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 10/2004
1	LipidsIBA 10/2004
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 10/2004
1	Myelin Basic ProteinIBA 10/2004
1	NucleotidesIBA 10/2004
1	Sphingosine-1-Phosphate ReceptorsIBA 08/2004
1	Fingolimod Hydrochloride (FTY720)FDA Link 08/2004
1	Myelin ProteinsIBA 08/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2004
1	4- ((2- (1- methyl- 2- pyrrolidinyl)ethyl)thio)phenol hydrochlorideIBA 10/2003
1	Cholinergic Agents (Cholinergics)IBA 10/2003

Therapy/Procedure

2	Ligation 11/2011 - 02/2011
1	Therapeutics 01/2021
1	Oral Administration 07/2009